Zacks.com重点推荐：Illumina、Commercial Metals与Newmont - Yahoo财经
Zacks.com featured highlights include Illumina, Commercial Metals and Newmont - Yahoo Finance
生命科学资讯
生物技术与制药领域的最新动态
扎克斯网站重点推介：Illumina、Commercial Metals与Newmont——纳斯达克精选
Zacks.com featured highlights include Illumina, Commercial Metals and Newmont - Nasdaq
Zacks.com重点推介Illumina、Commercial Metals及Newmont公司 - 雅虎财经新加坡版
Zacks.com featured highlights include Illumina, Commercial Metals and Newmont - Yahoo Finance Singapore
安盛集团减持赛默飞世尔科技股份$TMO - MarketBeat
Axa S.A. Lowers Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeat
高盛对赛默飞世尔科技股票给予买入评级初评 - Investing.com
Goldman Sachs initiates Thermo Fisher Scientific stock with Buy rating - Investing.com
安捷伦股票获高盛首予买入评级，基于增长前景看好——Investing.com
Agilent stock initiated with Buy rating at Goldman Sachs on growth outlook - Investing.com
Thermo Fisher Scientific推出Thermo Scientific X和S系列离心机 - SelectScience
Thermo Fisher Scientific introduces the Thermo Scientific X and S Series Centrifuges - SelectScience
安捷伦科技近期股价疲软后，其估值是否仍被高估？ - simplywall.st
Is Agilent Technologies Still Priced for Perfection After Recent Share Price Weakness? - simplywall.st
安捷伦科技近期股价疲软后，其估值是否仍被高估？ - simplywall.st
Is Agilent Technologies Still Priced for Perfection After Recent Share Price Weakness? - simplywall.st
ASH：默克考虑红细胞增多症项目前景，武田制药庆祝三期试验成功。
ASH: Merck mulls future of polycythemia program while Takeda takes phase 3 victory lap
糖原工程增强间充质干细胞的抗饥饿能力及其在肺纤维化治疗中的疗效
Glycogen engineering improves the starvation resistance of mesenchymal stem cells and their therapeutic efficacy in pulmonary fibrosis
自然场景中运动的动态尺度混合模型
A dynamic scale-mixture model of motion in natural scenes
人类内疚驱动与羞耻驱动利他行为的神经计算机制
Human neurocomputational mechanisms of guilt-driven and shame-driven altruistic behavior
安捷伦科技股价下跌看似剧烈，但跌幅究竟能有多深？- Trefis
Agilent Technologies Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis
《生物安全法案》有望随国防法案最终通过
Biosecure Act appears headed for final passage in defense bill
FDA批准瑞思迈AI技术个性化CPAP设置。
FDA clears Resmed AI for personalizing CPAP settings
随着减肥药大卖，礼来高管称公司有望成为全球创新的“支柱”。
With weight loss windfall, Lilly looks to become ‘backbone’ of global innovation: exec
FDA为CAR-T癌症疗法设定新高标准，要求证明其优越性。
FDA sets new, higher bar for CAR-T cancer treatments to prove superiority
#ASH25：一家生物技术公司转向白血病领域，能否与诺华一较高下？
#ASH25: Will a biotech’s pivot away from obesity let it compete with Novartis in leukemia?
Terns药物展现潜力，或挑战诺华白血病重磅疗法地位。
Terns drug shows potential to challenge Novartis’ blockbuster leukemia treatment